Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Bioorganic & Medicinal Chemistry Letters|May 12, 2010
3-Indolyl sultams as selective CRTh2 antagonistsL Nathan Tumey, Michael J Robarge, Elizabeth Gleason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid LeukemiaYoon-Chi Han, Jennifer Kahler, Nicole Piché-Nicholas, et al.
Bioconjugate Chemistry|July 15, 2016
Natural Product Splicing Inhibitors: A New Class of Antibody-Drug Conjugate (ADC) PayloadsSujiet Puthenveetil, Frank Loganzo, Haiyin He, et al.
Bioconjugate Chemistry|December 14, 2018
Natural Product Bis-Intercalator Depsipeptides as a New Class of Payloads for Antibody-Drug ConjugatesAnokha S Ratnayake, Li-Ping Chang, L Nathan Tumey, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Isosteric ramatroban analogs: selective and potent CRTH-2 antagonistsMichael J Robarge, David C Bom, L Nathan Tumey, et al.
ACS Medicinal Chemistry Letters|November 25, 2016
Optimization of Tubulysin Antibody-Drug Conjugates: A Case Study in Addressing ADC MetabolismL Nathan Tumey, Carolyn A Leverett, Beth Vetelino, et al.
Molecular Cancer Therapeutics|August 5, 2020
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung CancersEdmund I Graziani, Matthew Sung, Dangshe Ma, et al.
Cell Reports. Medicine|July 14, 2026
Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancersMeijie Tian, Katrina Jia, Jerry T Wu, et al.
Pageof 5